EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Qingda granule ameliorates vascular remodeling and phenotypic transformation of adventitial fibroblasts via suppressing the TGF-β1/Smad2/3 pathway

Meizhu Wu, Siyu Zhang, Wenqiang Zhang, Yuting Zhou, Zhi Guo, Yi Fang, Yanyan Yang, Zhiqing Shen, Dawei Lian, Aling Shen, Jun Peng

Journal of Ethnopharmacology · 2023

DOI: 10.1016/j.jep.2023.116535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2023. Verfasst von Meizhu Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Institute, The Second Affiliated Hospital & Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuz…. Hauptthemen laut MEDLINE: Transforming Growth Factor beta1, Hypertension. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Qingda granule (QDG) exhibits significant therapeutic effects on high blood pressure, vascular dysfunction, and elevated proliferation of vascular smooth muscle cells by inhibiting multiple pathways. However, the effects and underlying mechanisms of QDG treatment on hypertensive vascular remodeling are unclear. AIM OF THE STUDY: The aim of this study was to determine the role of QDG treatment in hypertensive vascular remodeling in vivo and in vitro. MATERIALS AND METHODS: An ACQUITY UPLC I-Class system coupled with a Xevo XS quadrupole time of flight mass spectrometer was used to characterize the chemical components of QDG. Twenty-five spontaneously hypertensive rats (SHR) were randomly divided into five groups, including SHR (equal volume of double distilled water, ddH2O), SHR + QDG-L (0.45 g/kg/day), SHR + QDG-M (0.9 g/kg/day), SHR + QDG-H (1.8 g/kg/day), and SHR + Valsartan (7.2 mg/kg/day) groups. QDG, Valsartan, and ddH2O were administered intragastrically once a day for 10 weeks. For the control group, ddH2O was intragastrically administered to five Wistar Kyoto rats (WKY group). Vascular function, pathological changes, and collagen deposition in the abdominal aorta were evaluated using animal ultrasound, hematoxylin and eosin and Masson staining, and immunohistochemistry. Isobaric tags for relative and absolute quantification (iTRAQ) was performed to identify differentially expressed proteins (DEPs) in the abdominal aorta, and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed. Cell Counting Kit-8 assays, phalloidin staining, transwell assays, and western-blotting were performed to explore the underlying mechanisms in primary isolated adventitial fibroblasts (AFs) stimulated with transforming growth factor-β 1 (TGF-β1) with or without QDG treatment. RESULTS: Twelve compounds were identified from the total ion chromatogram fingerprint of QDG. In the SHR group, QDG treatment significantly attenuated the increased pulse wave velocity, aortic wall thickening, and abdominal aorta pathological changes and decreased Collagen I, Collagen III, and Fibronectin expression. The iTRAQ analysis identified 306 DEPs between SHR and WKY and 147 DEPs between QDG and SHR. GO and KEGG pathway analyses of the DEPs identified multiple pathways and functional processes involving vascular remodeling, including the TGF-β receptor signaling pathway. QDG treatment significantly attenuated the increased cell migration, actin cytoskeleton remodeling, and Collagen I, Collagen III, and Fibronectin expression in AFs stimulated with TGF-β1. QDG treatment significantly decreased TGF-β1 protein expression in abdominal aortic tissues in the SHR group and p-Smad2 and p-Smad3 protein expression in TGF-β1-stimulated AFs. CONCLUSIONS: QDG treatment attenuated hypertension-induced vascular remodeling of the abdominal aorta and phenotypic transformation of adventitial fibroblasts, at least partly by suppressing TGF-β1/Smad2/3 signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor beta1HypertensionRatsAnimalsRats, Inbred WKYFibronectinsVascular RemodelingPulse Wave AnalysisRats, Inbred SHRCollagen Type IFibroblastsValsartanDrugs, Chinese Herbal

Stichwörter der Autor:innen

Adventitial fibroblastsHypertensionQingda granuleTGF-β1/Smad2/3Vascular remodeling

Substanzen

Transforming Growth Factor beta1FibronectinsCollagen Type IValsartanqingda granulesDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Clinical Research Institute, The Second Affiliated Hospital & Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, 350122, China; Fujian Key Laboratory of Integrative Medic…

Zitieren

APA

Wu, M., Zhang, S., Zhang, W., Zhou, Y., Guo, Z., Fang, Y., Yang, Y., Shen, Z., Lian, D., Shen, A., & Peng, J. (2023). Qingda granule ameliorates vascular remodeling and phenotypic transformation of adventitial fibroblasts via suppressing the TGF-β1/Smad2/3 pathway. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2023.116535

Vancouver

Wu M, Zhang S, Zhang W, Zhou Y, Guo Z, Fang Y, et al. Qingda granule ameliorates vascular remodeling and phenotypic transformation of adventitial fibroblasts via suppressing the TGF-β1/Smad2/3 pathway. Journal of Ethnopharmacology. 2023. doi:10.1016/j.jep.2023.116535

BibTeX
@article{Wu2023,
  author = {Wu, Meizhu and Zhang, Siyu and Zhang, Wenqiang and Zhou, Yuting and Guo, Zhi and Fang, Yi and Yang, Yanyan and Shen, Zhiqing and Lian, Dawei and Shen, Aling and Peng, Jun},
  title = {Qingda granule ameliorates vascular remodeling and phenotypic transformation of adventitial fibroblasts via suppressing the TGF-β1/Smad2/3 pathway},
  journal = {Journal of Ethnopharmacology},
  year = {2023},
  doi = {10.1016/j.jep.2023.116535}
}
Kostenlos starten →